TrialFrontiers in immunology2025

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer.

Xuwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.